Evidence map›Paper›PMID 22942427›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2012

Bone marrow dendritic cell-mediated regulation of TLR and B cell receptor signaling in B cells.

Vishal J Sindhava, Halide Tuna, Beth W Gachuki, David J DiLillo, Margarita G Avdiushko, Thandi M Onami, Thomas F Tedder, Donald A Cohen, Subbarao Bondada

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Emerging phagocytosis checkpoints in cancer immunotherapy.Signal transduction and targeted therapy · 2023
    Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Vishal J SindhavaDepartment of Microbiology, Immunology and Molecular Genetics, University of Kentucky College of Medicine, Lexington, KY 40536, USA.
Halide Tuna
Beth W Gachuki
David J DiLillo
Margarita G Avdiushko
Thandi M Onami
Thomas F Tedder
Donald A Cohen
Subbarao Bondada
University of Kentucky · USDuke Medical Center · USMarkey Cancer Center · USUniversity of Tennessee at Knoxville · US

Funding

Yessinia autotransporters (Yaps): Structure, function, and host responseU54AI057157 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI SEMPOWSKI, GREGORY D · 2003 to 2013
$91.4M
Supplement - Inflammatory Triggers in B Cell AutoimmunityU19AI056363 · NIAID · DUKE UNIVERSITY · PI ST. CLAIR, EUGENE WILLIAM · 2003 to 2017
$35.3M
Importance of CD5 for the function of regulatory T cellsR21AI076956 · NIAID · UNIVERSITY OF KENTUCKY · PI BONDADA, SUBBARAO · 2008 to 2009
$403k
NIAID NIH HHS AI076956NIAID NIH HHS AI56363NIAID NIH HHS R21 AI076956NIAID NIH HHS U19 AI056363NIAID NIH HHS U54 AI057157PHS HHS AQI057157
6 · The paper itself

Abstract

Dendritic cells (DCs) play an essential role in regulation of immune responses. In the periphery, Ag presentation by DCs is critical for adaptive responses; for this reason, DCs are often targets of adjuvants that enhance vaccine responses. Activated mature DCs enhance B cell activation and differentiation by providing cytokines like BAFF and a proliferation-inducing ligand. However, the role of immature DCs in B cell tolerance is not well studied. Recently, mouse immature bone marrow-derived DCs (iBMDCs) have been shown to suppress anti-IgM-induced B cell activation. In this study, we tested the ability of mouse DCs to modulate B cell functions during TLR activation. We found that iBMDCs potently suppressed proliferation and differentiation of various B cell subsets on TLR stimulation. However, iBMDCs did not affect CD40-mediated B cell activation. Optimal suppression of B cell activation by iBMDCs required cell contact via the CD22 receptor on B cells. The B cell suppression was a property of iBMDCs or DCs resident in the bone marrow (BM), but not mature BM-derived DCs or DCs resident in the spleen. Presence of iBMDCs also enhanced the Ag-induced apoptotic response of BM B cells, suggesting that the suppressive effects of iBMDCs may have a role in B cell tolerance.

Indexed as

AnimalsB-Lymphocyte SubsetsBone Marrow CellsCell DifferentiationCells, CulturedDendritic CellsMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicReceptors, Antigen, B-CellReceptors, Antigen, T-CellSignal TransductionSpleenReceptors, Antigen, B-CellReceptors, Antigen, T-Cell

Identifiers

PMID22942427
PMCPMC3495978
OpenAlexW1678391491

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.